31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
When a judicial opinion refers to a “bitter feud”, a plaintiff “beset by acrimony”, and a “rock...
Read More >
Seyfarth Synopsis: The Ninth Circuit’s recent decision in Salazar v. McDonald’s Corporation is we...
Read More >
An employer’s vacation policy did not violate the Colorado Wage Claim Act (CWCA), despite stating t...
Read More >
Markets gave a warm welcome to the Biden administration on Wednesday, as strong tech performance and...
Read More >
The SEC announced settled charges against Andeavor LLC for controls violations relating to a stock b...
Read More >
Hiring the right lawyers is a critical component of any law firm’s success. But developing an inter...
Read More >